Vaginal culture for IVF allows two mothers to carry the same pregnancy: Is more always better?
OA: gold
CC-BY-NC-ND-4.0
AI-generated summary
This paper evaluates the INVOcell intravaginal culture device as a lower-cost fertility treatment option, noting similar live birth rates to IVF but unclear cost savings.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
•Intravaginal culture (IVC) is not a new technology but is gaining in popularity•The INVOcell device is marketed as a lower cost treatment option to in-vitro fertilization (IVF)•Previous studies done by the INVOcell owned company have shown similar live birth rates between INVOcell IVC and IVF•It is unclear how much of a cost savings is present with use of IVC compared to traditional IVF•IVC may represent a viable option for fertility treatment in select patients.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-09-13T09:25:22.628771+00:00
- unpaywall
- last seen: 2026-05-21T05:10:58.409756+00:00
License: CC-BY-NC-ND-4.0